and can be disfiguring, interfering with the ability to talk, swallow, and even breathe," said Paul Swiecicki, M.D., associate medical director for the Oncology Clinical Trials Support Unit at Rogel."As of now, there's no test to monitor for its recurrence except watching for symptoms or potentially using aaims to identify different clinical ways that providers can more strategically track for recurrence.
Patients with HPV-positive cancers were found to develop recurrent disease significantly later than those that were HPV-negative, and also were more likely to spread to the lungs. Taken together, these characteristics may help create a"surveillance" method in the future that combines routineSwiecicki is quick to mention that, at this point, the results of this study are largely theoretical and provide a helpful framework to direct further research.
Not only is this test more sensitive and able to detect a smaller number of DNA fragments in blood, but it's innovative in other ways too, says Chandan Bhambhani, Ph.D., the first author of the study."We achieved this level of sensitivity by looking for nine different pieces of the HPV genome DNA all at once," said Bhambhani, research lab specialist.
Education Education Latest News, Education Education Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BBCNewsNI - 🏆 95. / 52 Read more »
Source: Glasgow_Live - 🏆 4. / 97 Read more »
Source: nottslive - 🏆 96. / 52 Read more »